文献速递瓣膜病与结构性心脏病

低外科风险患者接受单纯介入或外科主动脉瓣置换的院内数据与1年结果:德国主动脉瓣注册研究

Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY).
PubMed 文献 · Eur Heart J · 2019-01-01

经加权倾向评分模型比较,TAVI组院内和30天生存率显著高于SAVR组,但1年生存率无显著差异。

要点

  • 低外科风险(STS评分<4%)患者中,TAVI组院内生存率98.5%高于SAVR组97.3%。
  • TAVI组30天生存率98.1%显著高于SAVR组97.1%,1年生存率两组无显著差异。
  • 该分析提示低外科风险患者TAVI与SAVR的1年生存相似,TAVI院内生存更优。

核心结论

  • 在低外科风险患者中,加权比较显示TAVI与SAVR的1年生存率相似,而TAVI的院内生存率更高。

主要发现

  • TAVI组院内生存率98.5%,SAVR组97.3%,差异显著(P=0.003)。
  • TAVI组30天生存率98.1%,SAVR组97.1%,差异显著(P=0.014)。
  • 1年生存率TAVI组90.0%,SAVR组91.2%,差异无统计学意义(P=0.158)。

临床怎么用

  • 对于STS评分<4%的低外科风险主动脉瓣狭窄患者,TAVI可作为SAVR的替代选择之一,需结合患者具体情况个体化决策。

局限性

  • TAVI患者年龄显著更大且合并症显著更多,尽管采用加权倾向评分模型校正,仍可能存在残余混杂。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Transcatheter aortic valve implantation (TAVI) has become the standard treatment for patients with severe aortic valve stenosis at high surgical risk and may be considered for patients with intermediate risk. During the last few years, an increasing number of patients with low surgical risk have been treated with TAVI. In this study, low-risk patients undergoing isolated TAVI or surgical aortic valve replacement (SAVR) were analysed using data from the German Aortic Valve Registry (GARY). METHODS AND RESULTS: All patients with a Society of Thoracic Surgeons Score of <4% undergoing TAVI or SAVR in 2014 and 2015 were evaluated. A total of 20 549 low surgical risk patients remained for further analysis, comprising 14 487 surgical patients and 6062 TAVI patients. Since TAVI patients were significantly older and had significantly more co-morbidities, a weighted propensity score model was used to compare SAVR and TAVI patients for in-hospital, 30-day, and 1-year mortality. Transcatheter aortic valve implantation patients showed a significantly higher in-hospital and 30-day survival than SAVR patients (in hospital survival TAVI vs. SAVR: 98.5% vs. 97.3%; P = 0.003; 30-day survival TAVI vs. SAVR: 98.1% vs. 97.1%; P = 0.014). At 1 year, survival rates did not differ significantly (survival TAVI vs. SAVR: 90.0% vs. 91.2%; P = 0.158). CONCLUSION: In this first GARY analysis of low-risk patients, weighted comparison showed similar 1-year survival for TAVI and SAVR and higher in-hospital survival for TAVI patients.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Bekeredjian R, Szabo G, Balaban Ü, et al. Patients at low surgical risk as defined by the Society of Thoracic Surgeons Score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1-year results from the German Aortic Valve Registry (GARY). Eur Heart J. 2019. PMID: 30445543. doi:10.1093/eurheartj/ehy699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。